Create an alert
to follow the executive moves at Debiopharm Investment.
Alexion Pharmaceuticals has announced the acquisition of Portola Pharmaceuticals (posted on May 11, 2020).
Thermo Fisher Scientific has announced the acquisition of Qiagen (posted on Mar 5, 2020).
Sanofi has acquired Synthorx (posted on Jan 23, 2020).
Debiopharm Investment has 1,386 competitors including Genentech (United States (USA)), Eurofins (France) and Callitas Therapeutics (Canada). Debiopharm Investment is owned by Debiopharm International.
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.